PULM - Pulmatrix, Inc.
7.16
-0.099 -1.383%
Share volume: 16,700
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.26
-0.10
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-10-2023 | 11-09-2023 | 11-08-2024 | 05-10-2024 | 08-13-2024 | 11-08-2024 | |
| Total revenue | 1.499 M | 1.844 M | 1.753 M | 2.202 M | 5.885 M | 1.552 M | 366.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.499 M | 1.844 M | 1.753 M | 2.202 M | 5.885 M | 1.552 M | 366.000 K | |
| 23.02% | -4.93% | 25.61% | 167.26% | -73.63% | -76.42% | |||
| Operating expenses | 6.084 M | 5.835 M | 5.692 M | 4.427 M | 5.138 M | 4.835 M | 3.023 M | |
| Selling general and admin | 2.210 M | 1.670 M | 1.729 M | 911.000 K | 1.626 M | 2.001 M | 2.209 M | |
| Research and development | 3.874 M | 4.165 M | 3.963 M | 3.516 M | 3.512 M | 2.834 M | 814.000 K | |
| Total expenses | 6.084 M | 5.835 M | 5.692 M | 4.427 M | 5.138 M | 7.453 M | 3.023 M | |
| -4.09% | -2.45% | -22.22% | 16.06% | 45.06% | -59.44% | |||
| Operating income | -4.585 M | -3.991 M | -3.939 M | -2.225 M | 747.000 K | -5.901 M | -2.657 M | |
| Ebit | -4.670 M | -4.052 M | -3.991 M | -2.275 M | 665.000 K | -5.944 M | -2.688 M | |
| Pretax income | -4.448 M | -3.816 M | -3.774 M | -2.083 M | 825.000 K | -5.811 M | -2.587 M | |
| -14.21% | -1.10% | -44.81% | -139.61% | -804.36% | -55.48% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.448 M | -3.816 M | -3.774 M | -2.083 M | 825.000 K | -5.811 M | -2.587 M | |
| 14.21% | 1.10% | 44.81% | 139.61% | -804.36% | 55.48% |